203 395

Cited 7 times in

5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion

Authors
Choi, JH; Kim, YB; Lim, HY; Park, JS; Kim, HC; Cho, YK; Han, SW; Kim, MW; Joo, HJ
Citation
Hepato-gastroenterology, 54(73):290-297, 2007
Journal Title
Hepato-gastroenterology
ISSN
0172-6390
Abstract
BACKGROUND/AIMS: Although adjuvant chemotherapy has demonstrated small but significant survival benefit in locally advanced gastric cancer in several meta-analyses, optimal chemotherapy regimen remains to be determined.



METHODOLOGY: We retrospectively analyzed the survival of 207 gastric cancer patients (stage IB: 19, II: 65, IIIA: 58, IIIB: 28, IV: 37) who underwent 5-fluorouracil (5-FU), mitomycin-C (MMC), and polysaccharide-K (PSK) chemoimmunotherapy (CITX) after curative resection (FM group). The survival of FM group was compared with that of historical control cohort of 103 patients with almost identical stage distribution who received 5-FU and doxorubicin-based chemotherapy (FA group).



RESULTS: Five-year disease-free survival and overall survival (OS) of FM group were 58.7% and 59.1%, respectively. Frequent perineural invasion was significantly associated with poor OS (p = 0.01) in multivariate analysis. There was no statistically significant difference in 5-year OS (59.1% vs. 56.2%, p = 0.637) between FM and FA groups. FM group showed superior 5-year OS (84.4% vs. 67.6%, p = 0.019) compared with FA group in stage IB or II patients without significant difference (p = 0.222) in stage IIIA to IV.



CONCLUSIONS: 5-FU, MMC, and PSK CITX is as effective as 5-FU and doxorubicin-based chemotherapy. Moreover, frequent perineural invasion seems to be an important poor prognostic factor.
MeSH terms
Adenocarcinoma/drug therapy*Adenocarcinoma/mortalityAdenocarcinoma/pathologyAdenocarcinoma/surgeryAdultAntibiotics, Antineoplastic/administration & dosage*Antineoplastic Combined Chemotherapy Protocols/therapeutic use*Chemotherapy, AdjuvantFemaleFluorouracil/administration & dosage*HumansImmunotherapyMaleMiddle AgedMitomycin/administration & dosage*Multivariate AnalysisNeoplasm InvasivenessPeripheral Nerves/pathology*PrognosisStomach Neoplasms/drug therapy*Stomach Neoplasms/mortalityStomach Neoplasms/pathologyStomach Neoplasms/surgeryv
PMID
17419278
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
AJOU Authors
최, 진혁김, 영배박, 준성김, 효철조, 용관한, 상욱김, 명욱주, 희재
Files in This Item:
Full-Text Not Available.txtDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse